RecruitingNot applicable

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies in Patients With Heart Failure

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 3 months

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Both groups will have an in-person session (delivered on the day of a clinic appointment for regular follow-up) one month after baseline and phone boosters every other week for up to 3 months."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partners to help them work together and build skills to overcome their individual barriers to adherence in order to 1) improve and sustain patient medication adherence; 2) reduce hospitalization; 3) improve quality of life. If effective, this intervention will support long-term medication adherence, thus reducing hospitalizations related to heart failure and quality of life.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria - Patient Participants: * confirmed diagnosis of heart failure (HF), either systolic or diastolic HF * ave suboptimal medication adherence * have a care partner (CP) (either spouse, daughter/son, partner, other relative, friend) who is identified by the patient as the person most involved in HF care * willingness to have a CP be involved in their medication taking * have undergone evaluation of HF and prescribed stable doses of HF medications for at least 3 months * live in a setting where the patient is responsible for their ow medication administration * willing to use the SimpleMed+ (i.e., an electronic pillbox to measure objective medication adherence) * availability by phone Exclusion Criteria - Patient Participants: * cognitive impairment as indicated by having difficulties to understand and give informed consent * a recent hospitalization within 3 months of study enrollment * co-existing end-stage renal disease or terminal illness such as advanced malignancy, or any other condition with less than 1-year life expectancy * psychotic illness * current alcohol dependence or other substance abuse * inability to speak English or other communication barrier * currently or have received any similar self-care intervention recently in the past year Inclusion Criteria - Care Partners: * unpaid family member, friend, partner, or other relation who is involved in the patients' care at least 3 times a week, designated by the patient * willing to receive interventions with the patient together * 18 years of age or older Exclusion Criteria - Care Partners: * cognitive impairment as indicated by having difficulties to understand and give informed consent * coexisting terminal illness * non-English speaking or any other communication barrier

Study sites (1)

KY